openPR Logo
Press release

Erdosteine Market to see 8% CAGR till 2025 | Top Key Players are Recipharm AB, Taj Pharmaceuticals, Delta Finochem, Alitair Pharmaceuticals, Hanmi Pharmaceuticals, Jigs Chemical

Erdosteine Market

Erdosteine Market

Escalating demands for mucus regulating medicines due to the rising level of air pollution is expected to boost global erdosteine market trends in the forecast years. Erdosteine is an active pharmaceutical ingredient that is used to manufacture drugs that alleviate cold symptoms by making mucus less viscous and sticky and opening up airways.

Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/3371

Driven by growing occurrences of common respiratory issues like cold, bronchitis, and cough, the global erdosteine market is estimated to observe significant profits through 2025. Erdosteine has a broad range of applications in the production of drugs to ameliorate and control the symptoms that arise due to excessive mucus production, which is likely to drive the overall industry share. Excess amount of mucus is produced owing to several immune disorders, smoking and allergies like dirt and pollen.

Erdosteine is utilized in the production of medicines that regulate mucus production. Erdosteine has antibacterial and mucolytic properties which helps in mucus production’s regulation. As per a research report by Global Market Insights, Inc., global erdosteine market is estimated to surpass $160 million through 2025.

With respect to end-use segment, the pharmaceutical sector is predicted to witness substantial growth in the forthcoming timeframe. The segment was valued for more than $45 million in 2018. Growing cases of chronic respiratory issues like emphysema, chronic obstructive pulmonary disorders and asthma caused due to increase in the number of air contaminants like combustion particles, ground-level ozone, nitrogen and sulfur oxides, ammonia, and nitrates, would be a major factor fueling erdosteine market growth.

Get Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/erdosteine-market

Rising disposable income levels and changing lifestyles are driving the smoking trend in emerging APAC economies such as India, Indonesia and China. Chronic smoking has been linked to accelerated mucus production due to diseases like chronic bronchitis and smokers cough.

Moreover, smoking also has a detrimental effect on cilia, which is crucial for healthy movement of mucus to the throat. The destruction of cilia causes mucus to accumulate in the bronchioles, causing it to thicken overtime, leading to throat irritation and coughing. These symptoms associated with smoking are expected to boost erdosteine market outlook across the region significantly, particularly through cough and cold clearing drugs in coming years.

Major companies profiled in the erdosteine market are Recipharm AB, Taj Pharmaceuticals Limited, Wuhan Hezhong Bio-Chemical Manufacture Co. Ltd., Delta Finochem Pvt. Ltd., Alitair Pharmaceuticals, Inc., Salvavidas Pharmaceutical Private Limited, Zhejiang Kangle Pharmaceutical Co. Ltd., Wuhan Yuancheng Pharmaceutical, Hanmi Pharmaceuticals Co. Ltd., Shandong Luoxin Pharmaceutical, Asmoh Laboratories Ltd., Hikma Pharmaceuticals, Jigs Chemical.

Browse More News:

https://www.prnewswire.com/news-releases/flow-chemistry-market-value-to-hit-2-5-billion-by-2026-global-market-insights-inc-300961694.html

https://www.prnewswire.com/news-releases/powder-coating-market-to-exceed-usd-17-bn-by-2025-global-market-insights-inc-300940763.html

Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Erdosteine Market to see 8% CAGR till 2025 | Top Key Players are Recipharm AB, Taj Pharmaceuticals, Delta Finochem, Alitair Pharmaceuticals, Hanmi Pharmaceuticals, Jigs Chemical here

News-ID: 2108083 • Views:

More Releases from Global Market Insights, Inc.

Rare Sugar Market Top 3 Trends, Covid-19 Outbreak, Factors Driving, Threats, Cha …
Rising awareness regarding health & fitness and the subsequent shift in consumer trends towards low-calorie sweeteners will boost rare sugar market share over the forecast spell. Recent years have marked a steady rise in the prevalence of cardiovascular ailments, diabetes, and obesity, among other chronic conditions, which have triggered a massive change in consumer perceptions towards health. This in turn has led to a surge in demand for various functional foods
Global Selenium Yeast Market Industry Assessment, Trends, Competitive Landscape, …
The selenium yeast market is anticipated to register substantial gains on account of rising inclination towards organic additives in animal nutrition, with an aim to improve livestock health and production. Consumers are steadily becoming aware of the downsides associated with using synthetic additives. As a result, they are preferring selenium yeast feed grades over other counterparts to provide balanced nutrition to their livestock. According to Global Market Insights Inc estimates
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key players Eaton, Schneider, Siemens, Hitachi, Powell, Hubbell
Power Distribution Component Market Share, Size, Trends by 2025 | Leading Key pl …
Global Power Distribution Component Market Report offers market overview, segmentation by types, application, countries, key manufactures, cost analysis, industrial chain, sourcing strategy, downstream buyers, marketing strategy analysis, distributors/traders, factors affecting market, forecast and other important information for key insight. Request a sample of this research report @ https://www.gminsights.com/request-sample/detail/3091 Voltage rating have acted as a standard industry protocol toward the installation of power components reliant on regulatory preference, deployment areas, and the group
Prenatal Vitamin Ingredients Market New Entrants, Risk Factors, Market Expansion …
The rise in the instances of miscarriages on account of poor diet and hygiene will anchor the consumption of prenatal vitamin ingredients. Excessive intake of junk food has resulted in the scarcity of important nutrients in pregnant women that could adversely affect the fetus health and development. Furthermore, prenatal vitamin ingredients possess additional nutritional components that are not so easily sourced from regular food items and products. Prenatal vitamin ingredients can

All 5 Releases


More Releases for Erdosteine

Erdosteine Market Global Industry Analysis and Forecast Till 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and
Erdosteine Market Global Industry Analysis and Trends till 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and
Erdosteine Market: Future market projections for forthcoming years
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and
Erdosteine Market - Trends And Opportunities For The Industry By 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and
Global Erdosteine Tablets Market Size, Status and Forecast 2021
The report on the Erdosteine Tablets market gives a meticulous introduction about the Erdosteine Tablets market in the intial part of the report and further the information such as emerging trends, regional markets, application, policy analysis, end-users, and value chain structure are discussed. The report contains complete details about global the market, which comprises the past market scenario, the current situation of the market, and the future conditions forecasted. The
Erdosteine Market Research Report 2024
Erdosteine is an oral mucolytic agent used for treatment of chronic obstructive bronchitis. Erdosteine is also used for treatment of acute and chronic bronchitis. It is an orphan drug. Erdosteine stimulates mucus production and increases mucociliary transport, which improves expectoration. It consists of two sulfhydryl groups freed after metabolic transformation in the liver. These released sulfhydryl groups help to break the disulphide bonds. This makes bronchial secretions more fluid and